Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATI-7505 on Gastrointestinal Transit in Healthy Volunteers
NCT01094821Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naronapride in gastrointestinal motility disorder, sponsored by Mayo Clinic. Started Jan 2005; status: completed.
02
Drugs
naronapride
03
Conditions
gastrointestinal motility disorder
Beyond the preview
Go deeper on NCT01094821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01094821.